CPT code 55708: Prostate biopsy, transrectal MRI-US fusion2026 Medicare rate & RVUs in Oregon
Reports ultrasound-guided transrectal prostate sampling that uses MRI-ultrasound fusion to target the first MRI-identified lesion.
Medicare pays $414.08–$450.05 for 55708 in the office in Oregon, from Rest of Oregon to Portland, OR. Which amount applies depends on the service address.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What 55708 covers
A urologist uses a transrectal ultrasound probe and fusion software to align previously obtained MRI images with live ultrasound, then guides biopsy sampling to the first targeted prostate lesion. This approach is used when imaging identifies a suspicious focus, such as during evaluation of an elevated PSA or abnormal prostate findings. The route is through the rectum; it is not a transperineal or in-bore MRI biopsy.
Report the service for the first lesion targeted with this transrectal MRI-fusion method; code 55715 may apply to additional lesions. Document the imaging-fusion approach, route, lesion targeting, and sampling performed. The 0-day global period includes same-day preoperative and postoperative care. When multiple procedures occur in one session, Medicare pays the highest-valued procedure in full and reduces the others to 50%. Modifier 50 is inappropriate. Assistant-at-surgery payment requires documented medical necessity; co-surgeons and team surgery are not permitted.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where 55708 pays more and less in Oregon
| Payment locality | Office | Facility |
|---|---|---|
| Portland, OR | $450.05 | $172.48 |
| Rest of Oregon | $414.08 | $165.24 |
How the 55708 rate is calculated
Each of 55708’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · 55708
RVUs × geographic indexes × conversion factor
Work3.39
3.39 RVUs× 1.000 GPCI
Practice expense8.74
8.74 RVUs× 1.000 GPCI
Malpractice0.43
0.43 RVUs× 1.000 GPCI
Adjusted RVUs
12.5600
Conversion factor
$33.4009
Medicare rate
$419.52
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for 55708
The CMS indicators that decide how 55708 is paid alongside other services.
CMS payment indicators · 55708
Prostate biopsy, transrectal MRI-US fusion
| Rule | CMS value | What it means |
|---|---|---|
| Global period | 000 | Same-day global: pre- and post-op care on the day of the procedure is included. |
| Multiple procedures | 2 | Standard reduction: highest-valued procedure at 100%, others at 50%. |
| Bilateral (modifier 50) | 0 | The 150% bilateral adjustment doesn’t apply. |
| Assistant at surgery (80/81/82/AS) | 0 | Not paid without supporting documentation. |
| Co-surgeons (62) | 0 | Not permitted. |
| Team surgery (66) | 0 | Not permitted. |
| Professional/technical | 0 | Physician service: no professional/technical split. |
What modifiers do to the payment
Modifier 51 · payment effect
With and without the modifier
55708 without 51 · national office
$419.52
Prostate biopsy, transrectal MRI-US fusion
55708-51 · Second procedure: 50%
$209.76
When this isn’t the highest-valued procedure in the session, Medicare pays 50% of its fee schedule amount (the highest is paid at 100%).
55708 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- 55707Prostate biopsyTransrectal, ultrasound guided
- Use 55708 when the transrectal biopsy uses MRI-ultrasound fusion to target a lesion. Code 55707 describes transrectal ultrasound-guided biopsy without that fusion method.
- 55710Prostate biopsyTransperineal MRI-ultrasound fusion
- Both involve ultrasound-guided MRI-fusion prostate biopsy, but 55710 uses a transperineal route; 55708 uses a transrectal route.
- 55713Prostate biopsyIn-bore CT or MRI guidance
- Code 55713 describes an in-bore CT or MRI biopsy. Code 55708 uses transrectal ultrasound guidance with MRI-ultrasound fusion.
55708 billing questions
How is this different from 55707?
55708 involves transrectal ultrasound guidance combined with MRI fusion to target a lesion. Code 55707 describes transrectal ultrasound-guided biopsy without the MRI-fusion method.
Can 55715 be reported with 55708?
Yes. Code 55708 reports the first targeted lesion, and 55715 is the add-on code for each additional lesion when applicable.
Should modifier 50 be appended for bilateral sampling?
No. CMS identifies bilateral adjustment as inappropriate for this code.
What documentation supports reporting 55708?
Document the transrectal route, ultrasound guidance with MRI fusion, the targeted lesion, and the biopsy sampling performed.
How are multiple procedures in the same session paid?
Medicare pays the highest-valued procedure in full and reduces the other procedures to 50%. Same-day preoperative and postoperative care is included in this code's 0-day global period.
When is assistant-at-surgery payment allowed?
Only when medical necessity for the assistant is documented. Co-surgeons and team surgery are not permitted.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file lines behind this rate
Fee sheets · Coming soon
Put 55708 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist